Royal London Asset Management Ltd. Has $340.14 Million Stake in HCA Healthcare, Inc. $HCA

Royal London Asset Management Ltd. decreased its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 33.6% during the 4th quarter, HoldingsChannel reports. The fund owned 728,575 shares of the company’s stock after selling 368,376 shares during the quarter. HCA Healthcare comprises about 0.7% of Royal London Asset Management Ltd.’s portfolio, making the stock its 16th largest holding. Royal London Asset Management Ltd.’s holdings in HCA Healthcare were worth $340,143,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Victory Capital Management Inc. boosted its stake in shares of HCA Healthcare by 3.0% during the 4th quarter. Victory Capital Management Inc. now owns 116,133 shares of the company’s stock worth $54,218,000 after buying an additional 3,436 shares during the last quarter. Vontobel Holding Ltd. increased its position in shares of HCA Healthcare by 36.6% during the 4th quarter. Vontobel Holding Ltd. now owns 5,649 shares of the company’s stock worth $2,637,000 after purchasing an additional 1,515 shares during the last quarter. Boston Partners increased its holdings in HCA Healthcare by 2.7% during the fourth quarter. Boston Partners now owns 199,771 shares of the company’s stock worth $93,265,000 after buying an additional 5,257 shares during the last quarter. Storgate LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $763,000. Finally, Martingale Asset Management L P bought a new stake in HCA Healthcare in the fourth quarter valued at approximately $285,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HCA. Mizuho raised their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Royal Bank Of Canada dropped their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Barclays decreased their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $506.14.

Check Out Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Stock Up 2.3%

HCA stock opened at $387.25 on Friday. The company’s 50-day moving average price is $429.60 and its two-hundred day moving average price is $473.48. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The firm has a market cap of $85.91 billion, a P/E ratio of 13.32, a P/E/G ratio of 1.20 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the business earned $6.45 earnings per share. The business’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.